The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta

$42,806,353

Department of Health and Human Services·Food and Drug Administration

to REI SYSTEMS, INC.

healthactiveONGOING · MOD OF 2025 CONTRACT
WORK BEGAN2025-09-30·LATEST ACTION2026-05-06·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75F40125F19009_7524_75F40121A00019_7524
Award description

ORDER FOR OII IMPORTS, SIRCE, ALM, OCI, ADMIN O&M, DME

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: medium
In plain English

FDA systems and operations for drug import oversight, regulatory compliance, and administrative management.

Sub-sectors
fda-operationsdrug-import-systemsadministrative-infrastructure
Why this matters

Ensures FDA can process and regulate pharmaceutical imports, critical to drug supply chain security and public health protection.

Supply-chain signal

Strengthens FDA's capacity to monitor and control pharmaceutical imports, affecting how drugs enter U.S. distribution channels.

U.S.–China competition angle

Relevant to monitoring drug ingredients and finished pharmaceuticals sourced from China and other countries.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002080.

Period of performance
Start
2025-09-30
End
2026-10-30
Status
activein 164 days
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.